Key Takeaways
- Supply chain normalization unlocks growth: After chip shortages and COVID disruptions capped FY23 revenue growth at 13%, management says component availability has returned to normal, clearing the path for the INR1,700 crore order book to convert.
- Backward integration into PCBs is imminent: The Raneal subsidiary plant is built and trials are done; commercial production starts in July after certifications, with captive orders already in hand.
- Margins are a "wait and see" story: Management explicitly declined to quantify the margin uplift from PCB insourcing, disputed analyst assumptions of 20-25% EMS margins, and asked for three months of production data before committing to any number.
- Product company ambition has a clock: DCX aims to become a product company within 1.5 to 2 years via technology acquisition from Israel, France, and the US, but nothing is in writing yet.
- What to watch next quarter: Whether Raneal begins commercial production on schedule in July, the first disclosed PCB margin contribution, and any new OEM order wins from the pipeline management says is building.
Supply Chain & Growth Normalization
- FY23 growth brake removed: Revenue growth moderated to 13% in FY23 after a 55%+ CAGR run from FY17-FY22, a deceleration management attributed entirely to external global supply chain disruptions for military-grade components, not to internal capability, cash flows, or working capital.
- Chip shortage resolved: The heavy disturbance from chip shortages and COVID-related disruptions last year has been brought under control; sufficient raw material is now available and component manufacturers are returning to normal.
- Order book provides multi-year visibility: The INR1,700 crore order book is a scheduled PO stretching over two to two-and-a-half years, not a single-year backlog.
- Pipeline confidence without confirmed POs: Management is working with many local and foreign OEMs and reports very good inquiries from new geographical areas after becoming an EMS company, but no confirmed PO exists beyond the current INR1,600 crore+ order book.
- Export tilt expected: Management expects exports to grow more than domestic in upcoming days given the large market opportunity.
Dr. Raghavendra Rao: "When the company has grown from a platform of about INR25 crores in 2017 to about INR1,102 crores in FY 22. Obviously after such a long pass of very high growth rate of 55% CAGR plus and then to repeat such a level of performance in the following year also may or may not be sustainable depending upon lot of not internal resources and..."
Raneal PCB Subsidiary: The Margin & Strategy Pivot
- Backward integration rationale: Raneal Advance Systems, a 100% subsidiary, was floated for backward integration into Printed Circuit Board Assembly; the plant is completely set, machinery installed, and trials taken.
- Commercial timeline: Customer visits and line approval expected in June; ES-9100 certification takes a minimum of ~1.5 months; commercial production starts in July with POs already on hand.
- Year-one business mix: For this year, only captive business is planned; management expects roughly 70-80% captive (DCX internal consumption) and 20-30% direct business from the market.
- Strategic positioning, not just margin: Management framed Raneal as a capability play to capture more orders: DCX now has cable, system integration, and PCB under one roof, which it sees as a big advantage in the market.
- Margin quantification refused: Management declined to give a specific margin number, stating PCB assembly margins depend on board complexity, layers, class-2/class-3 programs, and project mix; it asked to be allowed to start production first and report results in three months.
- 25% margin assumption disputed: When an analyst suggested PCB market margins are 20-25%, management explicitly pushed back, stating no EMS company makes 25% margin and that 12-14% gross margin is the observed range in EMS.
Dr. Raghavendra Rao: "I think you have a wrong information, even though the 25% margin work doesn't work anywhere. I've never seen in my 25 years' experience the 25% margin EMS business."
Product Company Ambition
- 1.5-to-2-year target: Management stated with certainty that DCX will become a product company within 1.5 to 2 years, working with different countries including Israel, France, and the US on technology acquisition.
- Make in India hook: The strategy targets the 408-line items on the positive indigenous list, where foreign partners can give technology transfer to an Indian company or form a JV with 49% foreign and 51% Indian majority to supply to the Ministry of Defence.
- No written agreements yet: The technology acquisition process is described as positive but nothing is in writing yet.
- Vision as a technology company: DCX aims to acquire knowledge from foreign OEMs and supply to the MOD under the Make in India program, moving beyond pure manufacturing.
Dr. Raghavendra Rao: "But one thing I assure you that DCX become in within a 1.5 years to two years become a product company. That is for sure."
Financial Health & Risk Mitigation
- Working capital spike explained: The increase was driven by two factors: roughly 50% of sales occurred in the last quarter, mostly in March, so collection time extended beyond period-end; and a major part of raw materials reached the factory after the first fortnight, so could not be converted into finished goods.
- Working capital capacity: Management estimates INR400-500 crore of working capital can manage a ~INR1,400 crore top line, though actual requirement depends on project mix, component lead times, customer credit terms of 60-90 days, and back-to-back payment arrangements.
- Forex loss addressed: A INR4 crore forex loss occurred in Q4 despite converting forex loans to INR because actual buy/sell transactions still generate forex impact; forex loans have been reduced to zero as of 31 March 2023, and forward coverage has been taken for all inward receivables to reduce future losses.
- Borrowing trajectory: Borrowing will increase proportionately with turnover beyond ~INR1,400 crore; currently the company uses pure packing credit with no cash credit, and an interest arbitrage benefit exists because interest on FDs exceeds interest paid to the banker.
- Customer advance discipline: Management stated it never touches any big PO without a customer advance, and complete BOM guarantee is taken care of in the contracting modality.
- Customer concentration reduced: Over-reliance on IAI has reduced from ~90-95% to ~55% in FY22; more domestic customers have been added and the offset-to-non-offset business mix has widened.
Capacity & Expansion
- System integration capacity: The facility is fully lined with 7-8 programs and can easily build 4-5 programs in parallel; no capex is required.
- Cable and wire harness expansion: Management expects some big POs and plans to expand the existing cable business in an SEZ or DTH area with a small capex of INR4-5 crore.
- Manpower to double: Headcount is expected to double this year as Raneal requires more people; currently 100-150 people are sufficient for the existing business and are loaded at 80%.
- Employee cost structure: Employee cost is low at INR10 crore on INR1,200 crore turnover because the products are high-value defense and aerospace modules that do not require large manpower.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Raneal commercial production | Plant ready; certifications in process; POs on hand | July 2023 |
| Raneal margin disclosure | First results to be announced once production starts | Three months from now |
| Product company transition | Technology acquisition from Israel, France, US; nothing in writing yet | 1.5 to 2 years |
| Quarterly earnings calls | Management committed to regular quarterly calls | Starting from this call onward |
| Forex loss reduction | Forward coverage on all inward receivables; no restatement after forex loan conversion to zero; considerable reduction expected but not zero | Going forward |
| Cable business expansion | Small capex of INR4-5 crore for SEZ/DTH area expansion | Undated |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Revenue | ₹1,254 cr (FY23), +13% YoY from ₹1,102 cr in FY22 |
| Employee cost | ₹10 cr on turnover of ~₹1,200 cr |
| Order book | ₹1,700 cr, 60% export and 40% domestic |
| Forex loss | ~₹4 cr in Q4 FY23 |
| Forex loans outstanding | Zero as on 31 March 2023 |
| Gross borrowings | ₹503 cr as on 31 March 2023 |
| PCB procurement from outside | ~₹800 cr to ₹900 cr out of ₹1,200 cr+ revenue |
| Employee headcount | ~150 people directly |
| Manpower utilization | 80% |
| IAI customer concentration | Reduced from ~90–95% to ~55% in FY22 |
| Credit period | 30 to 45 days |
| Cable and wire harness capex requirement | ~₹4 cr to ₹5 cr |
| Raneal subsidiary capex spent | ~₹35 cr to ₹40 cr |
| Normalized working capital requirement | ₹400–₹500 cr for a turnover of ₹1,400 cr |